Absorption |
Blood-Brain Barrier | BBB+ | 0.9793 |
Human Intestinal Absorption | HIA+ | 0.9843 |
Caco-2 Permeability | Caco2+ | 0.8391 |
P-glycoprotein Substrate | Substrate | 0.7618 |
P-glycoprotein Inhibitor | Inhibitor | 0.8573 |
Inhibitor | 0.8387 |
Renal Organic Cation Transporter | Inhibitor | 0.8520 |
Distribution |
Subcellular localization | Lysosome | 0.4552 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7875 |
CYP450 2D6 Substrate | Substrate | 0.8918 |
CYP450 3A4 Substrate | Substrate | 0.7408 |
CYP450 1A2 Inhibitor | Inhibitor | 0.8374 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9176 |
CYP450 2D6 Inhibitor | Inhibitor | 0.8932 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9025 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.7971 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6074 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8890 |
Inhibitor | 0.8029 |
AMES Toxicity | Non AMES toxic | 0.8735 |
Carcinogens | Non-carcinogens | 0.8971 |
Fish Toxicity | High FHMT | 0.9873 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9740 |
Honey Bee Toxicity | Low HBT | 0.8502 |
Biodegradation | Not ready biodegradable | 0.9967 |
Acute Oral Toxicity | III | 0.8138 |
Carcinogenicity (Three-class) | Non-required | 0.7124 |